Overwhelmed by the cannabis earnings reports? Here's the metric that Jim Cramer watches.
Plus, why investors should care about the yield curve, and a closer look at Tilray's quarter.
Jim Cramer said that he believes that Canopy Growth could be the next Amazon. Here's why he thinks that the cannabis company could be the next Amazon.
Jim Cramer wrote about the three different scenarios that could happen to Elon Musk as Judge Nathan considers her decision.
Jim Cramer thinks that Bristol-Myer's deal with Celgene is a positive thing, despite Starboard's resistance.
Bristol-Myers, Tilray, and Elon Musk are some of the top headlines in business news Tuesday. Here's what Jim Cramer's watching.
Here's what you need to know about Tilray's earnings, Elon Musk's fight with the SEC and Bristol-Myers fight with Starboard over Celgene. Jim Cramer talks the markets
An engineered overshoot in inflation may be what the gold market needs right now.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.